ABSTRACT
Background and aims Problematic gaming has been linked to increased levels of psychotic-like experiences (PLEs) in youth, but the role of environmental factors remains unclear. Using affordance theory, this study aimed to examine the association of problematic gaming with PLEs and the role of environmental factors.
Methods Participants were 6492 youth (39.2% female) who reported playing video games, from the Adolescent Brain Cognitive Development Study in the U.S. Measures included problematic gaming, peer environment (number of close friends), school environment (teachers, activities, etc.), family environment (parental monitoring), and PLEs. We examined whether the peer, school, and family environments at age 12 were associated with problematic gaming and moderated its association with PLEs at age 13.
Results Higher protective scores for the school and family environments at age 12 were independently associated with lower levels of problematic gaming at age 12 (respectively B=−0.15; 95% CI: −0.21, −0.10 and B=−2.39; 95% CI: −2.71, −2.07) and age 13 (B=−0.05; 95% CI: −0.10, −0.00 and B=−0.79; 95% CI: −1.11, −0.47). The peer environment was not associated with problematic gaming. Higher levels of problematic gaming at age 12 were associated with higher levels of PLEs at age 13 (B=0.13; 95% CI: 0.09, 0.17), with no significant interaction with the environmental variables.
Discussion and conclusions Positive school and family environments may be protective against problematic gaming in adolescence but do not appear to attenuate the putative effect of problematic gaming on PLEs. The results provide partial support to an affordance-based conceptualization of problematic gaming.
Competing Interest Statement
CDC has received honoraria and/or travel support from Angelini, Johnson&Johnson, and Viatris for work unrelated to this study.
Funding Statement
VP is supported by an award from the Fonds de recherche du Québec - Santé and Ministère de la santé et des services sociaux (FRQS-MSSS). BSK received support from the National Institute of Mental Health (NIMH K23-MH129684). SG and CDC received support for this work as part of the Youth-GEMs project, funded by the European Union's Horizon Europe Program under Grant Agreement Number 101057182. CDC received support from Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation (PI20/00721, PI23/00625) and the European Commission (HE YOUTHreach 101156514).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data used in the preparation of this article were obtained from the Adolescent Brain Cognitive Development (ABCD) Study (https://abcdstudy.org), held in the NIMH Data Archive (NDA). The ABCD Study is supported by the National Institutes of Health and additional federal partners under award numbers U01DA041048, U01DA050989, U01DA051016, U01DA041022, U01DA051018, U01DA051037, U01DA050987, U01DA041174, U01DA041106, U01DA041117, U01DA041028, U01DA041134, U01DA050988, U01DA051039, U01DA041156, U01DA041025, U01DA041120, U01DA051038, U01DA041148, U01DA041093, U01DA041089, U24DA041123, U24DA041147. A full list of supporters is available at https://abcdstudy.org/federal-partners.html. A listing of participating sites and study investigators can be found at https://abcdstudy.org/consortium_members/. This manuscript reflects the views of the authors and may not reflect the opinions or views of the NIH or ABCD consortium investigators. The ABCD data used in this report came from http://dx.doi.org/10.15154/z563-zd24.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.